Comment on "Subgroup Analysis from a Phase 1/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients with Age-Related Cataract". Roy AS. Am J Ophthalmol 2024 Sep 19:S0002-9394(24)00435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roy AS. Comment on "Subgroup Analysis from a Phase 1/2 Randomized Clinical Trial of 2.6% EDTA Ophthalmic Solution in Patients with Age-Related Cataract". Am J Ophthalmol 2024 Sep 19:S0002-9394(24)00435.
PMID: 39306317